echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Active Ingredient Products News > The Synthetic Routes of Diltiazem hydrochloride

    The Synthetic Routes of Diltiazem hydrochloride

    • Last Update: 2023-05-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Diltiazem hydrochloride is a pharmaceutical drug that is used to treat cardiovascular diseases, such as hypertension, angina, and heart failure.
    It works by relaxing the smooth muscle in the blood vessels, which allows the blood to flow more easily and reduces the pressure on the heart.


    There are several different synthetic routes that can be used to prepare diltiazem hydrochloride, each with its own advantages and disadvantages.
    The following are three common synthetic routes for diltiazem hydrochloride:


    1. The first synthetic route involves the reaction of 2,3-dimethyl-1,4-benzoxazepine with 4-chloro-2,5-dimethylthiazoline to form the key intermediate 2-(4-chloro-2,5-dimethylthiazol-1-yl)-1,4-benzoxazepine.
      This intermediate can then be reacted with hydriodic acid to form the final compound, diltiazem hydrochloride.
      This route is efficient and straightforward, but it requires the use of some hazardous reagents.
    2. The second synthetic route involves the reaction of 1,4-benzoxazepine with 4-chloro-2,5-dimethylthiazoline and sodium hydroxide to form the key intermediate 2-(4-chloro-2,5-dimethylthiazol-1-yl)-1,4-benzoxazepine.
      This intermediate can then be treated with thiosulfonic acid to form the final compound, diltiazem hydrochloride.
      This route is also efficient and straightforward, but it requires the use of some hazardous reagents.
    3. The third synthetic route involves the reaction of 1,4-benzoxazepine with 4-chloro-2,5-dimethylthiazoline and potassium hydroxide to form the key intermediate 2-(4-chloro-2,5-dimethylthiazol-1-yl)-1,4-benzoxazepine.
      This intermediate can then be treated with thiosulfonic acid and sodium chloride to form the final compound, diltiazem hydrochloride.
      This route is less efficient than the other two routes, but it does not require the use of hazardous reagents.

    Once the diltiazem hydrochloride has been synthesized, it can be purified using a variety of methods, such as recrystallization, chromatography, and precipitation.
    The purified diltiazem hydrochloride can then be formulated into a pharmaceutical product, such as a tablet or a capsule, for use in treating cardiovascular diseases.


    In conclusion, there are several different synthetic routes that can be used to prepare diltiazem hydrochloride, each with its own advantages and disadvantages.
    The three routes described above are commonly used in the pharmaceutical industry, and they involve the use of various reagents and purification methods to produce the final product.
    The choice of synthetic route depends on various factors, such as cost, efficiency, and the availability of the starting materials.



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.